Pharyngitis Treatment Market size was valued at USD 2.19 billion in 2023 and is projected to exceed USD 4.03 billion by the end of 2036, registering over 4.8% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of pharyngitis treatment is evaluated at USD 2.27 billion.
The growth of the market can be attributed to the increasing cases of diseases that cause pharyngitis, such as, measles, whooping cough, and chickenpox, among others. According to the data by World Health Organization (WHO), in 2018, there were more than 140 000 deaths caused by measles, globally. Bacterial infection in the pharynx is the major cause of pharyngitis. The growing demand for treatment solution for the sore throat and pain, is estimated to boost the market growth. Moreover, increasing investment in developing measles vaccines, is also estimated to boost the market growth. As per other report by WHO, about 86% of the world's children received measles vaccines, in 2018. Between 2000-2018, use of vaccines prevented an estimate of 23.2 million deaths.
Growth Drivers
Challenges
|
2023 |
|
|
Forecast Year |
2024–2036 |
|
CAGR |
4.8% |
|
Base Year Market Size (2023) |
USD 2.19 billion |
|
Forecast Year Market Size (2036) |
USD 4.03 billion |
|
Regional Scope |
|
The pharyngitis treatment market is segmented by route of administration into oral, intravenous, and others, out of which, the oral segment is anticipated to hold the largest share in the market during the forecast period on account of easy availability of oral drugs, along with ease in intake of the drug. On the basis of end-user, the pharmacy segment is estimated to garner significant share during the forecast period owing to the effectiveness of over-the-counter drugs, along with the easy availability of medicines in pharmacies.
Our in-depth analysis of the global market includes the following segments:
|
Treatment |
|
|
Route of Administration |
|
|
End-User |
|
Regionally, the pharyngitis treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America industry is predicted to dominate majority revenue share by 2036, impelled by high healthcare expenditure, highest health awareness among people, and increasing investment in R&D activities. As per another report by WHO, the per capita healthcare expenditure of North America valued USD 10,050.279, in 2018. Moreover, presence of major pharmaceutical companies, along with high investment in development and distribution of vaccines, is estimated to boost the market growth. The market in the Asia Pacific region is estimated to witness highest CAGR over the forecast period, owing to the high prevalence of pharyngitis backed by high population and increasing risk of infections. Moreover, growing public healthcare system in countries, such as, India, and China, is projected to further boost the pharyngitis treatment market growth.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?